Search research articles
Contact Us
Filters
Showing results (1-10 of 761) with videos related to
Page
of 77
Sort By:
European Journal of Heart Failure
|
April 17, 2020
Health-related quality of life scores: ending the minimum 5-point difference as the clinically meaningful threshold
João Pedro Ferreira
European Journal of Heart Failure
|
April 7, 2021
Cognitive function assessment for personalized heart failure disease management programmes
João Pedro Ferreira
JACC. Heart Failure
|
September 28, 2024
Patiromer and MRA Doses in Patients With Current or Past Hyperkalemia
João Pedro Ferreira
Journal of the American College of Cardiology
|
May 20, 2021
Omecamtiv Mecarbil: A Personalized Treatment for Patients With Severely Impaired Ejection Fraction
João Pedro Ferreira
European Journal of Heart Failure
|
May 9, 2021
Circulating levels of procollagen type I carboxy-terminal propeptide reflect myocardial fibrosis
João Pedro Ferreira
JACC. Heart Failure
|
January 5, 2019
Balancing Benefits and Risks of Spironolactone in HFpEF and Chronic Kidney Disease Patients: Mind the Gap of Biological Monitoring!
Patrick Rossignol, João Pedro Ferreira
JACC. Heart Failure
|
January 11, 2025
We Need Simpler and More Integrated Guidelines in Cardio-Kidney-Metabolic Diseases
João Pedro Ferreira, Faiez Zannad
Journal of Cardiac Failure
|
May 25, 2025
Screening for Undiagnosed Heart Failure: A Viewpoint
João Pedro Ferreira, Faiez Zannad
JACC. Heart Failure
|
November 5, 2016
Oral Anticoagulant Agents in Patients With Atrial Fibrillation and Heart Failure: Does Heart Failure Status Influence Efficacy and Safety?
Faiez Zannad, João Pedro Ferreira
European Heart Journal
|
April 25, 2025
Obesity, metrics of central adiposity, and prognostic significance in heart failure with preserved and mildly reduced ejection fraction
Pedro Marques, João Pedro Ferreira
Page
of 77
Search research articles
Search
Showing results (1-10 of 761) with videos related to
Sort By:
Page
of 77
European Journal of Heart Failure
|
April 17, 2020
Health-related quality of life scores: ending the minimum 5-point difference as the clinically meaningful threshold
João Pedro Ferreira
European Journal of Heart Failure
|
April 7, 2021
Cognitive function assessment for personalized heart failure disease management programmes
João Pedro Ferreira
JACC. Heart Failure
|
September 28, 2024
Patiromer and MRA Doses in Patients With Current or Past Hyperkalemia
João Pedro Ferreira
Journal of the American College of Cardiology
|
May 20, 2021
Omecamtiv Mecarbil: A Personalized Treatment for Patients With Severely Impaired Ejection Fraction
João Pedro Ferreira
European Journal of Heart Failure
|
May 9, 2021
Circulating levels of procollagen type I carboxy-terminal propeptide reflect myocardial fibrosis
João Pedro Ferreira
JACC. Heart Failure
|
January 5, 2019
Balancing Benefits and Risks of Spironolactone in HFpEF and Chronic Kidney Disease Patients: Mind the Gap of Biological Monitoring!
Patrick Rossignol, João Pedro Ferreira
JACC. Heart Failure
|
January 11, 2025
We Need Simpler and More Integrated Guidelines in Cardio-Kidney-Metabolic Diseases
João Pedro Ferreira, Faiez Zannad
Journal of Cardiac Failure
|
May 25, 2025
Screening for Undiagnosed Heart Failure: A Viewpoint
João Pedro Ferreira, Faiez Zannad
JACC. Heart Failure
|
November 5, 2016
Oral Anticoagulant Agents in Patients With Atrial Fibrillation and Heart Failure: Does Heart Failure Status Influence Efficacy and Safety?
Faiez Zannad, João Pedro Ferreira
European Heart Journal
|
April 25, 2025
Obesity, metrics of central adiposity, and prognostic significance in heart failure with preserved and mildly reduced ejection fraction
Pedro Marques, João Pedro Ferreira
Page
of 77